Kim P. Kamdar - Jun 1, 2021 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Director
Signature
/s/ Lisa A. Kraeutler, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4
Date filed
6/1/2021, 04:40 PM
Previous filing
May 26, 2021
Next filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Conversion of derivative security +4.4M +4395.63% 4.5M Jun 1, 2021 By Domain Partners IX, L.P. F1
holding OMIC Common Stock 15K Jun 1, 2021 By Domain Associates, LLC F1
holding OMIC Common Stock 15K Jun 1, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Series Seed Convertible Preferred Stock Conversion of derivative security $0 -2.67M -100% $0.00* 0 Jun 1, 2021 Common Stock 2.67M By Domain Partners IX, L.P. F1, F2
transaction OMIC Series A Convertible Preferred Stock Conversion of derivative security $0 -1.29M -100% $0.00* 0 Jun 1, 2021 Common Stock 1.29M By Domain Partners IX, L.P. F1, F2
transaction OMIC Series B Convertible Preferred Stock Conversion of derivative security $0 -436K -100% $0.00* 0 Jun 1, 2021 Common Stock 436K By Domain Partners IX, L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is a managing member of Domain Associates, LLC and of One Partner Square Associates IX, LLC, the sole general partner of Domain Partners IX, L.P. Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however she disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed her pecuniary interest therein and/or that are not actually distributed to her.
F2 All outstanding shares of convertible preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The convertible preferred stock had no expiration date.